Luca Boni
Researcher Next ID · RN-040371
Researcher · Biochemistry, Genetics and Molecular Biology
Portland, Ireland
- Works count
- 505
- Citation count
- 15,230
- H-index
- 59
- i10-index
- 196
Research interests
Publications
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00274-1
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study
The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00637-4
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(19)30862-9
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia
Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.18.01779
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient–Level Data
Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2018.78.0858
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00122-9
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1403108
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.34.4911
Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis
JNCI Journal of the National Cancer Institute · 2007 · https://doi.org/10.1093/jnci/djk196
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.
PubMed · 2003
Current projects
No projects listed.